Canopy Growth Q4 Revenue Up 10% to $71.2M; Full Year Revenue $284.6M
Canopy Growth Corporation announced its financial results for the fourth quarter and fiscal year ended March 31, 2026. The company reported a 10% year-over-year increase in consolidated net revenue for Q4 FY2026 to $71.2 million, and a 6% increase for the full fiscal year to $284.6 million. Growth was driven by strong performance in Canada medical cannabis and adult-use cannabis segments, with international markets also showing significant Q4 growth. However, Storz & Bickel revenue declined, and consolidated gross margin decreased, though adjusted gross margin improved. The company also highlighted the completion of the MTL Cannabis acquisition and ended the year with $131.3 million in net cash following a strategic recapitalization.
Key Highlights
- Canopy Growth reported Q4 FY2026 consolidated net revenue of $71.2M, a 10% increase year-over-year.
- Full-year FY2026 consolidated net revenue was $284.6M, up 6% from FY2025.
- Canada medical cannabis net revenue grew 27% in Q4 FY2026 and 18% for the full year.
- Canada adult-use cannabis net revenue increased 1% in Q4 FY2026 and 20% for the full year.
- International markets cannabis net revenue surged 68% in Q4 FY2026, though decreased 7% for the full year.
- Storz & Bickel net revenue decreased 14% in Q4 FY2026 and for the full year.
- Consolidated gross margin was 12% in Q4 FY2026, down from 16% in Q4 FY2025. Adjusted gross margin was 27% in Q4 FY2026.
- Net loss from continuing operations narrowed by 21% in Q4 FY2026 and 49% for FY2026.
Price Impact
More from CGC